The present invention relates to therapeutically active novel spiro[2,4]heptane amino carboxy compounds and derivatives thereof. Also provided is a method of preparing compounds of Formula (I), and pharmaceutical compositions comprising the compounds. The novel compounds act as modulators of metabotropic glutamate receptors and, as such, are useful in treating diseases of the central nervous system related to the metabotropic glutamate receptor system.
1
本发明涉及治疗活性新的螺[2,4]
庚烷氨基羧化合物及其衍
生物。还提供了制备式(I)化合物的方法和包含该化合物的药物组合物。这些新的化合物作为代谢型谷
氨酸受体的调节剂,因此在治疗与代谢型谷
氨酸受体系统相关的中枢神经系统疾病方面是有用的。